自閉症スペクトラム障害(ASD)治療薬の世界市場2018-2022

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR23830)
◆英語タイトル:Global Autism Spectrum Disorder Therapeutics Market 2018-2022
◆発行会社/調査会社:Technavio
◆商品コード:IRTNTR23830
◆発行日:2018年10月4日
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・製薬・バイオ
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[自閉症スペクトラム障害(ASD)治療薬の世界市場2018-2022]についてメールでお問い合わせはこちら
当調査レポートでは、自閉症スペクトラム障害(ASD)治療薬の世界市場について調査・分析し、市場概要、市場環境、自閉症スペクトラム障害(ASD)治療薬市場規模、治療薬別(抗精神病治療薬、抗うつ薬、その他治療薬)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。主な分析対象企業は、Allergan, GlaxoSmithKline, Janssen Pharmaceuticals, Pfizer, UCBなどです。
・エグゼクティブサマリー
・調査範囲・調査手法
・自閉症スペクトラム障害(ASD)治療薬の世界市場概要
・自閉症スペクトラム障害(ASD)治療薬の世界市場環境
・自閉症スペクトラム障害(ASD)治療薬の世界市場動向
・自閉症スペクトラム障害(ASD)治療薬の世界市場規模
・自閉症スペクトラム障害(ASD)治療薬の世界市場:業界構造分析
・自閉症スペクトラム障害(ASD)治療薬の世界市場:治療薬別(抗精神病治療薬、抗うつ薬、その他治療薬)
・自閉症スペクトラム障害(ASD)治療薬の世界市場:地域別市場規模・分析
・自閉症スペクトラム障害(ASD)治療薬の北米市場規模・予測
・自閉症スペクトラム障害(ASD)治療薬のヨーロッパ・中東・アフリカ市場規模・予測
・自閉症スペクトラム障害(ASD)治療薬のアジア太平洋市場規模・予測
・自閉症スペクトラム障害(ASD)治療薬の主要国分析
・自閉症スペクトラム障害(ASD)治療薬の世界市場:意思決定フレームワーク
・自閉症スペクトラム障害(ASD)治療薬の世界市場:成長要因、課題
・自閉症スペクトラム障害(ASD)治療薬の世界市場:競争環境
・自閉症スペクトラム障害(ASD)治療薬の世界市場:関連企業情報(ベンダー分析)
*** レポート概要(サマリー)***

About Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a developmental disorder that affects communication and behavior. ASD is associated with a wide range of symptoms such as core and associated. Core symptoms include impairment of social interaction and communication while associated spectrums include sleep deficits, language disability, mood swings, and self-injury.
Technavio’s analysts forecast the Global Autism Spectrum Disorder Therapeutics Market to grow to a market size of USD 3.8 billion during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the autism spectrum disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of autism spectrum disorder therapeutics across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, autism spectrum disorder therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Allergan
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Pfizer
• UCB
Market driver
• Increasing prevalence of autism spectrum disorders
• For a full, detailed list, view our report

Market challenge
• Strenuous diagnosis of autism spectrum disorder
• For a full, detailed list, view our report

Market trend
• Rising number of fast track designations
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

*** レポート目次(コンテンツ)***

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY TREATMENT THERAPEUTICS
• Segmentation by treatment therapeutics
• Comparison by treatment therapeutics
• Antipsychotic therapeutics – Market size and forecast 2017-2022
• Antidepressant therapeutics – Market size and forecast 2017-2022
• Other therapeutics – Market size and forecast 2017-2022
• Market opportunity by treatment therapeutics
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Rising number of fast track designations
• Increase in small molecules in drug development pipeline
• Increasing support from various foundations for research on ASD
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Pfizer
• UCB
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global CNS disorders therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Pipeline landscape by development phase 2017-2018
Exhibit 19: Late-stage pipeline molecules for treatment of ASD 2017-2018
Exhibit 20: Global – Market share by treatment therapeutics 2017-2022 (%)
Exhibit 21: Comparison by treatment therapeutics
Exhibit 22: Antipsychotic therapeutics – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Antipsychotic therapeutics – Year-over-year growth 2018-2022 (%)
Exhibit 24: Antidepressant therapeutics – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Antidepressant therapeutics – Year-over-year growth 2018-2022 (%)
Exhibit 26: Other therapeutics – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Other therapeutics – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by treatment therapeutics
Exhibit 29: Customer landscape
Exhibit 30: Global – Market share by geography 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: ALLERGAN – Overview
Exhibit 48: ALLERGAN – Business segments
Exhibit 49: ALLERGAN – Organizational developments
Exhibit 50: ALLERGAN – Geographic focus
Exhibit 51: ALLERGAN – Segment focus
Exhibit 52: ALLERGAN – Key offerings
Exhibit 53: ALLERGAN – Key customers
Exhibit 54: GlaxoSmithKline – Overview
Exhibit 55: GlaxoSmithKline – Business segments
Exhibit 56: GlaxoSmithKline – Organizational developments
Exhibit 57: GlaxoSmithKline – Geographic focus
Exhibit 58: GlaxoSmithKline – Segment focus
Exhibit 59: GlaxoSmithKline – Key offerings
Exhibit 60: GlaxoSmithKline – Key customers
Exhibit 61: Janssen Pharmaceuticals – Overview
Exhibit 62: Janssen Pharmaceuticals – Business segments
Exhibit 63: Janssen Pharmaceuticals – Organizational developments
Exhibit 64: Janssen Pharmaceuticals – Geographic focus
Exhibit 65: Janssen Pharmaceuticals – Segment focus
Exhibit 66: Janssen Pharmaceuticals – Key offerings
Exhibit 67: Janssen Pharmaceuticals – Key customers
Exhibit 68: Pfizer – Overview
Exhibit 69: Pfizer – Business segments
Exhibit 70: Pfizer – Organizational developments
Exhibit 71: Pfizer – Geographic focus
Exhibit 72: Pfizer – Segment focus
Exhibit 73: Pfizer – Key offerings
Exhibit 74: Pfizer – Key customers
Exhibit 75: UCB – Overview
Exhibit 76: UCB – Business segments
Exhibit 77: UCB – Organizational developments
Exhibit 78: UCB – Geographic focus
Exhibit 79: UCB – Key offerings
Exhibit 80: UCB – Key customers



*** 掲載企業 ***

Allergan, GlaxoSmithKline, Janssen Pharmaceuticals, Pfizer, UCB

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 女性用香水(フレグランス)市場動向(~2017):メキシコ
    Synopsis The report presents detailed data on consumption trends in the Female Fragrances category in Mexico, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers & acquisitions (of Fragran …
  • 世界の蛍光透視室市場2017
    Fluoroscopy Room Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germa …
  • テボ流通(株)(Daebo distribution)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 世界の音響パネル市場2017
    Acoustic Panels Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German …
  • スマートガスソリューションの世界市場
    This report analyzes the worldwide markets for Smart Gas Solutions in terms of Revenues in US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 20 …
  • フィブリノゲン欠乏症(Fibrinogen Deficiency):治療薬開発のグローバルパイプライン動向(2014年下半期版)
    Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014’, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)’s therapeutic pipeline. This report provides compr …
  • ソニック洗顔ブラシの世界市場
    In this report, the global Sonic Facial Cleansing Brush market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumpti …
  • NAB Private Wealth:企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "NAB Private Wealth" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. WealthInsight strictly f …
  • リモート車両診断の世界市場
    Notes:Production, means the output of Remote Vehicle Diagnostic Revenue, means the sales value of Remote Vehicle Diagnostic This report studies Remote Vehicle Diagnostic in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in glo …
  • Solaria Energia y Medio Ambiente S.A. (SLR)(代替エネルギー分野):企業のM&A・提携動向
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) designs, manufactures, supplies, and installs photovoltaic and thermal solutions for effective utilization of solar energy. The company has three lines of business, namely Photovoltaic modules, Turnkey projects and Thermal modules. Its product …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR23830 )"自閉症スペクトラム障害(ASD)治療薬の世界市場2018-2022" (英文:Global Autism Spectrum Disorder Therapeutics Market 2018-2022)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。